Seer Inc Cl A (SEER) said after close Tuesday that it lost $0.37 per share in quarter two 2023.
On the revenue line, the company reported $4 million, missing estimates by $1.1 million.
In the same quarter a year ago, the company lost $0.37 per share on revenue of $3.6 million.
The stock is down 29.83% to $3.27 after the report.
The average recommendation from Wall Street analysts was a Hold which may get revised based on this new data.
Trading in the five days leading up to the report earned Seer Inc Cl A a Neutral Sentiment Rank from InvestorsObserver.
Seer Inc Cl A has performed a little below average during the past few months. Before the report, Seer Inc Cl A received a Long-Term Technical Rank by InvestorsObserver of 47, putting it in the bottom half of stocks. The firm set a 52-week low on April 28, 2023 at $3.07 and set a 52-week high on August 10, 2022 at $13.4.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome.
News Home
Seer Inc Cl A Down 29.83% To $3.27 After Earnings Beat
Mentioned in this article
